Vaccine effectiveness studies have conclusively demonstrated the benefit of COVID-19 vaccines in reducing individual symptomatic and severe disease, resulting in reduced hospitalisations and intensive care unit admissions.1 However, the impact of vaccination on transmissibility of SARS-CoV-2 needs to be elucidated. A prospective cohort study in the UK by Anika Singanayagam and colleagues2 regarding community transmission… Continue reading Transmissibility of SARS-CoV-2 among fully vaccinated individuals
Category: Environment
Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19
The use of rapid lateral flow antigen testing (LFT) for SARS-CoV-2 has been questioned1, 2, 3 with uncorroborated4 reports of poor LFT sensitivity. The debate surrounding the use of the Innova Lateral Flow SARS-CoV-2 Antigen Test in the UK risks confusing policy makers internationally and potentially stalling deployment of LFTs in other countries.5 As scientists… Continue reading Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19
Triple Vaccinated put the most pressure on the NHS by far over the past 4 weeks according to UKHSA with 74% of Covid-19 hospitalisations recorded among the Vaccinated
The latest data available from the UK Health Security Agency confirms that the triple vaccinated population accounted for the majority of all Covid-19 hospitalisations between 20th Dec 21 and 16th Jan 22, with the double vaccinated population not far behind. The UK Health Security Agency (UKHSA) publish a weekly Covid-19 Vaccine Surveillance Report containing data… Continue reading Triple Vaccinated put the most pressure on the NHS by far over the past 4 weeks according to UKHSA with 74% of Covid-19 hospitalisations recorded among the Vaccinated
Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers
Observational evidence suggests that mask wearing mitigates transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is uncertain if this observed association arises through protection of uninfected wearers (protective effect), via reduced transmission from infected mask wearers (source control), or both. Objective:To assess whether recommending surgical mask use outside the home reduces wearers' risk… Continue reading Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers
Recognising Italy’s mistakes in the public health response to COVID-19
The Day of the Dead in Italy this year was not only a time for remembrance but also for demanding justice for lives lost to COVID-19. On Nov 2, 2021, members of the #Sereni (also known as Serene and Always United) Association demonstrated in Rome against institutional omerta (ie, law of silence) and for the… Continue reading Recognising Italy’s mistakes in the public health response to COVID-19
Intracranial infection cases up 60-fold since vaccines rolled out
But it can't be caused by the vaccines, masks, or swabs since all are "safe and effective" according to the CDC. My experts think it is all 3. Infectious disease docs say nothing is wrong, ignore it. https://stevekirsch.substack.com/p/intracranial-infection-cases-up-60
Persistence of clinically relevant levels of SARS-CoV2 envelope gene subgenomic RNAs in non-immunocompromised individuals
Highlights•SARS-CoV-2 activity is difficult to assess with conventional PCR assays.•Subgenomic RNA (sgRNA) may be a better proxy for infectivity.•Over 10% of COVID-19 patients were sgRNA positive beyond a 10-day period.•Long-duration sgRNA-positive patients were clinically unremarkable.•Vulnerable settings may require additional measures to minimize transmission.Abstract ObjectivesThis study aimed to evaluate the associations between COVID-19 severity and active… Continue reading Persistence of clinically relevant levels of SARS-CoV2 envelope gene subgenomic RNAs in non-immunocompromised individuals
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
SummaryBackgroundGiven the projected trends in population ageing and population growth, the number of people with dementia is expected to increase. In addition, strong evidence has emerged supporting the importance of potentially modifiable risk factors for dementia. Characterising the distribution and magnitude of anticipated growth is crucial for public health planning and resource prioritisation. This study… Continue reading Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
Worldwide Bayesian Causal Impact Analysis of Vaccine Administration on Deaths and Cases Associated with COVID-19: A BigData Analysis of 145 Countries
Policy makers and mainstream news anchors have promised the public that the COVID-19 vaccine rollout worldwide would reduce symptoms, and thereby cases and deaths associated with COVID-19. While this vaccine rollout is still in progress, there is a large amount of public data available that permits an analysis of the effect of the vaccine rollout… Continue reading Worldwide Bayesian Causal Impact Analysis of Vaccine Administration on Deaths and Cases Associated with COVID-19: A BigData Analysis of 145 Countries
2 Medical News 